Recipharm delivers first serialised batch to Saudi Arabia
Recipharm, the contract development and manufacturing organisation (CDMO), has delivered its first batch of serialised drug products to Saudi Arabia, following the introduction of new regulatory requirements in March 2017.The €300,000 project, which is in addition to a wider €40 million investment into new serialisation technology and processes to comply with the European Falsified Medicines Directive (FMD), enables Recipharm to supply serialised products to Saudi Arabia. Since the Saudi Food and Drug Authority (SFDA) enforced the latest version of the Saudi Drug Code (SDC), which aims